{
    "code": "52028183",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52028183",
    "time": "2021-12-17 06:03:10",
    "許可證字號": "衛部藥輸字第028183號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/11\/11",
    "發證\/登錄日期": "110\/11\/11",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202818307",
    "中文品名": "必肺暢氣化噴霧劑160\/7.2\/5.0微克",
    "英文品名": "BREZTRI AEROSPHERE 160\/7.2\/5.0 micrograms",
    "適應症": "適用於已接受吸入性皮質類固醇與長效β2作用劑合併治療、或長效β2作用劑與長效蕈毒鹼受體拮抗劑合併治療，而仍控制不佳的中至重度慢性阻塞性肺病 (COPD) 病人的維持治療。",
    "劑型": "102口腔氣化噴霧劑",
    "包裝": "100毫升以下鋁罐裝，鋁箔袋裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新複方",
    "監視期限": "115\/11\/11",
    "主成分略述": "glycopyrronium, FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE MICRONIZED",
    "限制項目": "02輸　入",
    "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
    "申請商地址": "台北市大安區敦化南路二段207號21樓",
    "主製造廠": [
        {
            "": "FRANCE",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208002420",
            "成分名稱": "glycopyrronium",
            "含量描述": "glycopyrronium, micronized (equivalent to glycopyrronium bromide......9.0 MCG；glycopyrrolate......9 MCG)",
            "含量": "7.2000000000",
            "單位": "MCG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1216003030",
            "成分名稱": "FORMOTEROL FUMARATE DIHYDRATE",
            "含量描述": "Formoterol fumarate dihydrate, micronized (equivalent to formoterol fumarate......4.8 MCG)",
            "含量": "5.0000000000",
            "單位": "MCG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "8406002102",
            "成分名稱": "BUDESONIDE MICRONIZED",
            "含量描述": "",
            "含量": "160.0000000000",
            "單位": "MCG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單-110-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028183&Seq=002&Type=9"
        },
        {
            "title": "20211021-BREZTRI 仿單核定本 (中文) clean-110-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028183&Seq=001&Type=9"
        },
        {
            "title": "藥罐標籤Canister-Label-110-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028183&Seq=004&Type=8"
        },
        {
            "title": "鋁箔袋標籤Foil-Label-110-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028183&Seq=003&Type=8"
        },
        {
            "title": "吸入器標籤Actuator-Label (微克)-110-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028183&Seq=002&Type=8"
        },
        {
            "title": "外盒carton (微克)-110-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028183&Seq=001&Type=8"
        }
    ]
}